4//SEC Filing
Moore Matthew Richard 4
Accession 0001787306-24-000022
CIK 0001787306other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 6:47 PM ET
Size
23.4 KB
Accession
0001787306-24-000022
Insider Transaction Report
Form 4
Moore Matthew Richard
SVP and Chief Business Officer
Transactions
- Award
Common Stock
2024-02-13+26,666→ 81,256 total - Award
Common Stock
2024-02-13+26,666→ 107,922 total - Award
Common Stock
2024-02-13+17,650→ 125,572 total - Award
Common Stock
2024-02-13+19,750→ 145,322 total - Award
Common Stock
2024-02-13+4,166→ 149,488 total - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-13−80,000→ 0 totalExercise: $28.72Exp: 2031-01-19→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-13−80,000→ 0 totalExercise: $28.72Exp: 2031-01-19→ Common Stock (80,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-13−35,300→ 0 totalExercise: $17.67Exp: 2032-03-03→ Common Stock (35,300 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-13−39,500→ 0 totalExercise: $15.82Exp: 2033-03-02→ Common Stock (39,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-13−12,500→ 0 totalExercise: $28.72Exp: 2031-01-18→ Common Stock (12,500 underlying)
Footnotes (9)
- [F1]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on January 19, 2021, and received in exchange for the option, these Restricted Stock Units ("RSUs") that vest in eight equal quarterly installments commencing May 1, 2024.
- [F2]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 3, 2022, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024.
- [F3]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, an option granted to the Reporting Person on March 2, 2023, and received in exchange for the option, these RSUs that vest in twelve equal quarterly installments commencing May 1, 2024.
- [F4]On February 13, 2024, the Issuer canceled, pursuant to the Issuer's option exchange program, performance-based option granted to the Reporting Person on January 19, 2021, and deemed earned on August 29, 2023, and received in exchange for the option, these RSUs that vest in eight equal quarterly installments commencing May 1, 2024.
- [F5]The canceled option vested as to 1/4 of the total shares on July 20, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vesting on July 20, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]The canceled option vested as to 1/4 of the total shares on January 11, 2022, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vesting on January 11, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F7]The canceled option vested as to 1/48 of the shares vest on each monthly anniversary measured from March 1, 2022 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F8]The canceled option vested as to 1/48 of the shares vest on each monthly anniversary measured from March 1, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F9]The canceled option vested as to 1/48 of the shares vest on each monthly anniversary of the milestone vesting commencement date, beginning on September 29, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001840191
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 6:47 PM ET
- Size
- 23.4 KB